PHARMAORIGIN ApS: Financial statements 2024
CVR: 29178291
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 94,000 compared with DKK 87,000 the year before. Equity in the 2024 report amounted to DKK 1,378,000. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 94,000
- Equity
- DKK 1,378,000
- Total Assets
- DKK 1,378,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | 94 t. | 1.4 mio. | - |
| 2023 | - | 0 | 87 t. | 1.3 mio. | - |
| 2022 | - | - | 47 t. | 1.2 mio. | - |
| 2021 | - | - | 40 t. | 1.1 mio. | - |
| 2020 | - | - | 13 t. | 1.1 mio. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PHARMAORIGIN ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK 87,000.
About PHARMAORIGIN ApS
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees (2008). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity in the 2025 report amounted to DKK 1,477,000.